ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 21 filers reported holding ANI PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,762,000 | -4.9% | 1,750,000 | 0.0% | 0.01% | +9.1% |
| Q3 2018 | $1,852,000 | -6.6% | 1,750,000 | 0.0% | 0.01% | -8.3% |
| Q2 2018 | $1,983,000 | -9.5% | 1,750,000 | -12.5% | 0.01% | -7.7% |
| Q1 2018 | $2,190,000 | -5.0% | 2,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $2,305,000 | +6.4% | 2,000,000 | 0.0% | 0.01% | +8.3% |
| Q3 2017 | $2,167,000 | +2.8% | 2,000,000 | 0.0% | 0.01% | -7.7% |
| Q2 2017 | $2,109,000 | -0.6% | 2,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $2,122,000 | +22.0% | 2,000,000 | +33.3% | 0.01% | +30.0% |
| Q4 2016 | $1,740,000 | -6.2% | 1,500,000 | 0.0% | 0.01% | -9.1% |
| Q3 2016 | $1,856,000 | +13.8% | 1,500,000 | 0.0% | 0.01% | +10.0% |
| Q2 2016 | $1,631,000 | +21.5% | 1,500,000 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $1,342,000 | -7.6% | 1,500,000 | 0.0% | 0.01% | -11.1% |
| Q4 2015 | $1,452,000 | – | 1,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 18,779 | $20,315,000 | 3.48% |
| Wellesley Asset Management | 58,241 | $63,483,000 | 3.40% |
| DLD Asset Management, LP | 16,000,000 | $17,360,000 | 1.71% |
| Worth Venture Partners, LLC | 1,720,000 | $1,891,000 | 1.64% |
| Perceptive Advisors | 15,000,000 | $16,238,000 | 0.31% |
| D.A. DAVIDSON & CO. | 125,000 | $13,367,000 | 0.26% |
| CAMDEN ASSET MANAGEMENT L P /CA | 2,030,000 | $2,203,000 | 0.07% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,500,000 | $1,641,000 | 0.06% |
| Jefferies Group LLC | 2,591,000 | $2,815,000 | 0.02% |
| GABELLI FUNDS LLC | 2,000,000 | $2,167,000 | 0.01% |